- Home
- WYHG vs TERN Comparison
WYHG vs TERN Comparison
Compare WYHG & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYHG
- TERN
- Stock Information
- Founded
- WYHG 1915
- TERN 2017
- Country
- WYHG China
- TERN United States
- Employees
- WYHG N/A
- TERN N/A
- Industry
- WYHG
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- WYHG
- TERN Health Care
- Exchange
- WYHG NYSE
- TERN Nasdaq
- Market Cap
- WYHG 362.4M
- TERN 310.8M
- IPO Year
- WYHG 2024
- TERN 2021
- Fundamental
- Price
- WYHG $9.75
- TERN $2.90
- Analyst Decision
- WYHG
- TERN Buy
- Analyst Count
- WYHG 0
- TERN 5
- Target Price
- WYHG N/A
- TERN $15.63
- AVG Volume (30 Days)
- WYHG 138.0K
- TERN 1.0M
- Earning Date
- WYHG 05-23-2025
- TERN 05-08-2025
- Dividend Yield
- WYHG N/A
- TERN N/A
- EPS Growth
- WYHG N/A
- TERN N/A
- EPS
- WYHG 0.20
- TERN N/A
- Revenue
- WYHG $133,289,812.00
- TERN N/A
- Revenue This Year
- WYHG N/A
- TERN N/A
- Revenue Next Year
- WYHG N/A
- TERN N/A
- P/E Ratio
- WYHG $5.23
- TERN N/A
- Revenue Growth
- WYHG 12.59
- TERN N/A
- 52 Week Low
- WYHG $3.55
- TERN $1.87
- 52 Week High
- WYHG $11.20
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- WYHG N/A
- TERN 47.68
- Support Level
- WYHG N/A
- TERN $2.93
- Resistance Level
- WYHG N/A
- TERN $3.40
- Average True Range (ATR)
- WYHG 0.00
- TERN 0.26
- MACD
- WYHG 0.00
- TERN -0.00
- Stochastic Oscillator
- WYHG 0.00
- TERN 10.89
About WYHG WING YIP FOOD HOLDINGS GROUP LTD SPON ADS EACH REP 1 ORD
Wing Yip Food Holdings Group Ltd is a meat producer. The company is mainly engaged in offering ready to eat and packaged meat dishes. Its product offerings include supreme crispy sausage, fully thin sausage, Chinese sausage, Dongguan Erba sausage, yellow scorpion sausage, alcohol sausage, and meat chop.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.